© 2023 by Conferences Website. Proudly created with Wix.com

UCLA Neurodegenerative Diseases Symposium


April 9, 2020

CNSI Auditorium

University of California, Los Angeles 

Trainee Talks

Graduate students and postdoctoral researchers are invited to submit abstracts to give 12-minute oral presentations about their research and ongoing activities in their labs. Click the registration button to submit you abstract. The deadline to submit is February 14, 2020.

Our Mission

The UCLA Neurodegenerative Diseases Symposium is a trainee-organized symposium highlighting cutting edge multidisciplinary research in the field of neurodegeneration being conducted by postdoctoral scholars, graduate students, and undergraduates. It is additionally an opportunity for researchers at all career stages studying neurodegeneration from different disciplines (clinical, basic science, and technology) across UCLA to gather together and engage in discussion. The day will consist of trainee talks and posters, a faculty keynote speaker, small-group discussion sessions, and a networking happy hour. Posters will be judged for cash prizes, and meals will be provided.


Postdoctoral researchers, graduate students, and undergraduate students are invited to submit abstracts for poster presentations. Posters will be judged and awarded cash prizes at each training level. Click the registration button to submit you abstract. The deadline to submit is February 14, 2020.

Deadline Extension!
Abstract Submission by February 28, 2020
Register by March 14, 2020

Distinguished Keynote Speaker:

Martin Kampmann, PhD

Associate Professor, University of California, San Francisco

Department of Biochemistry and Biophysics | Institute for Neurodegenerative Diseases
Investigator, Chan Zuckerberg Biohub
Paul G. Allen Distinguished Investigator

"Uncovering mechanisms and therapeutic strategies for neurodegenerative disease by CRISPR screens in iPSC-based models"

The goal the Kampmann lab is to elucidate cellular mechanisms of brain disease and to develop new therapeutic strategies. The lab has pioneered CRISPR-based functional genomics in cell types derived from induced pluripotent stem cells (iPSCs). A major focus is the investigation of neurodegenerative diseases in human iPSC-derived neurons, astrocytes, and microglia, and 3D assembloids/organoids. This approach has uncovered cellular pathways controlling the aggregation, prion-like spreading, and toxicity of tau, which is linked to Alzheimer’s Disease and other tauopathies.

Breakout Sessions

The breakout sessions are 30-minute small-group discussions led by a trainee moderator for the purpose of bringing together diverse faculty and trainees in order to address questions pertinent to advancing the field of neurodegenerative disease research. Topics will vary.